| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Strang Cancer Research Laboratory at The Rockefeller University, New York, New York 10021 [M. K., K. Y., K. F., M. L., A. M. C. B.]; Department of Cell Biology and Anatomy, Weill Medical College of Cornell University, New York, New York 10021 [A. M. C. B.]; Departments of Cell Biology [E. W., E. A., W. E.] and Molecular Genetics [R. K.], Albert Einstein College of Medicine, Bronx, New York 10461; and Ludwig Institute for Cancer Research, La Jolla, California 92093 [R. D. K.]
In mammalian cells, mismatch recognition has been attributed to two partially redundant heterodimeric protein complexes of MutS homologues, MSH2-MSH3 and MSH2-MSH6. We have conducted a comparative analysis of Msh3 and Msh6 deficiency in mouse intestinal tumorigenesis by generating Apc1638N mice deficient in Msh3, Msh6 or both. We have found that Apc1638N mice defective in Msh6 show reduced survival and a 67-fold increase in intestinal tumor multiplicity. In contrast, Msh3-deficient Apc1638N mice showed no difference in survival and intestinal tumor multiplicity as compared with Apc1638N mice. However, when Msh3 deficiency is combined with Msh6 deficiency (Msh3-/-Msh6-/-Apc1638N), the survival rate of the mice was further reduced compared to Msh6-/-Apc1638N mice because of a high multiplicity of intestinal tumors at a younger age. Almost 90% of the intestinal tumors from both Msh6-/-Apc1638N and Msh3-/-Msh6-/-Apc1638N mice contained truncation mutations in the wild-type Apc allele. Apc mutations in Msh6-/-Apc1638N mice consisted predominantly of base substitutions (93%) creating stop codons, consistent with a major role for Msh6 in the repair of base-base mismatches. However, in Msh3-/-Msh6-/-Apc1638N tumors, we observed a mixture of base substitutions (46%) and frameshifts (54%), indicating that in Msh6-/-Apc1638N mice frameshift mutations in the Apc gene were suppressed by Msh3. Interestingly, all except one of the Apc mutations detected in mismatch repair-deficient intestinal tumors were located upstream of the third 20-amino acid ß-catenin binding repeat and before all of the Ser-Ala-Met-Pro repeats, suggesting that there is selection for loss of multiple domains involved in ß-catenin regulation. Our analysis therefore has revealed distinct mutational spectra and clarified the roles of Msh3 and Msh6 in DNA repair and intestinal tumorigenesis.
This article has been cited by other articles:
![]() |
K. Yang, N. V. Popova, W. C. Yang, I. Lozonschi, S. Tadesse, S. Kent, L. Bancroft, I. Matise, R. T. Cormier, S. J. Scherer, et al. Interaction of Muc2 and Apc on Wnt Signaling and in Intestinal Tumorigenesis: Potential Role of Chronic Inflammation Cancer Res., September 15, 2008; 68(18): 7313 - 7322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Hegan, L. Narayanan, F. R. Jirik, W. Edelmann, R.M. Liskay, and P. M. Glazer Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6 Carcinogenesis, December 1, 2006; 27(12): 2402 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Chao and S. M. Lipkin Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis Nucleic Acids Res., February 6, 2006; 34(3): 840 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-C. Chen, S. Dudley, W. Hagen, D. Dizon, L. Paxton, D. Reichow, S.-R. Yoon, K. Yang, N. Arnheim, R. M. Liskay, et al. Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse Cancer Res., October 1, 2005; 65(19): 8662 - 8670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Campbell, P. N. Nation, and S. E. Andrew A Lack of DNA Mismatch Repair on an Athymic Murine Background Predisposes to Hematologic Malignancy Cancer Res., April 1, 2005; 65(7): 2626 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Lin, Y. Wang, S. J. Scherer, A. B. Clark, K. Yang, E. Avdievich, B. Jin, U. Werling, T. Parris, N. Kurihara, et al. An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis Cancer Res., January 15, 2004; 64(2): 517 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Chung and A. K. Rustgi The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications Ann Intern Med, April 1, 2003; 138(7): 560 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wong, K. Yang, M. Kuraguchi, U. Werling, E. Avdievich, K. Fan, M. Fazzari, B. Jin, A. M. C. Brown, M. Lipkin, et al. Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation PNAS, November 12, 2002; 99(23): 14937 - 14942. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kucherlapati, K. Yang, M. Kuraguchi, J. Zhao, M. Lia, J. Heyer, M. F. Kane, K. Fan, R. Russell, A. M. C. Brown, et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression PNAS, July 23, 2002; 99(15): 9924 - 9929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |